Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Copanlisib
Copanlisib
1032568-63-0
|
480.52
|
1.109
Copanlisib is a medication used to treat relapsed follicular lymphoma. It is a selective pan-Class I phosphoinositide 3-kinase (PI3K/Phosphatidylinositol-4,5-bisphosphate 3-kinase/phosphatidylinositide 3-kinase) inhibitor. The active ingredient in Aliqopa intravenous therapy is copanlisib dihydrochloride.
Aliqopa | BAY 80-6946 | copanlisib
Copanlisib is a medication used to treat relapsed follicular lymphoma. It is a selective pan-Class I phosphoinositide 3-kinase (PI3K/Phosphatidylinositol-4,5-bisphosphate 3-kinase/phosphatidylinositide 3-kinase) inhibitor. The active ingredient in Aliqopa intravenous therapy is copanlisib dihydrochloride.
Aliqopa | BAY 80-6946 | copanlisib
$41/5 mg
(EBC)
1
We provide 0 compound for Copanlisib